Betül KARAATMACA
(Ankara Şehir Hastanesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Çocuk Alerji ve İmmünoloji Bilim Dalı, Ankara, Türkiye)
Şule BÜYÜK YAYTOKGIL
(Ankara Şehir Hastanesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Çocuk Alerji ve İmmünoloji Bilim Dalı, Ankara, Türkiye)
İlknur KÜLHAŞ ÇELİK
(Ankara Şehir Hastanesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Çocuk Alerji ve İmmünoloji Bilim Dalı, Ankara, Türkiye)
Özge YILMAZ TOPAL
(Ankara Şehir Hastanesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Çocuk Alerji ve İmmünoloji Bilim Dalı, Ankara, Türkiye)
ERSOY CİVELEK
(Ankara Şehir Hastanesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Çocuk Alerji ve İmmünoloji Bilim Dalı, Ankara, Türkiye)
Müge TOYRAN
(Ankara Şehir Hastanesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Çocuk Alerji ve İmmünoloji Bilim Dalı, Ankara, Türkiye)
Emine DİBEK MISIRLIOĞLU
(Ankara Şehir Hastanesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Çocuk Alerji ve İmmünoloji Bilim Dalı, Ankara, Türkiye)
Yıl: 2021Cilt: 19Sayı: 2ISSN: 1308-9234Sayfa Aralığı: 92 - 99İngilizce

49 0
Macrolide Allergy in Children and the Negative Predictive Value of Drug Provocation Tests in Mild Index Reactions
Objective: Macrolide allergy is rarely reported, and there is limited knowledge of hypersensitivity reactions (HRs) in children. The negative predictive value (NPV) of drug provocation tests (DPTs) for macrolides is unresolved. We aim to evaluate the clinical features of macrolide allergy in children, and determine the NPV of macrolide DPTs. Materials and Methods: Pediatric patients who were referred to our allergy department with a suspicion of macrolide allergy were evaluated by DPTs with or without prior skin tests between 2011 and 2020. Characteristics of the HRs and patients, the results of skin and DPTs were recorded. At least three months after evaluation of the patients with allergy work up, telephone interviews were performed. Patients were asked whether they had reused the suspected macrolide or not. Patients who reported HR during subsequent drug intake were invited for reevaluation. Results: A total of 160 children (161 reactions) (55.6% male) with a suspicion of macrolide allergy were enrolled for the study, and all children had a mild index reaction. The median age was 48 (18-102) months, and the median time between the suspected allergic reaction and allergy work-up was 3 (2-8) months. The most frequently reported suspected agent was clarithromycin, in 151 patients (94.4%). Macrolide allergy was confirmed in 8 (5%) patients. Only one patient reported skin eruptions upon reuse despite a negative DPT and he was invited to be reevaluated. A second DPT was performed resulting in urticarial lesions. The NPV was found to be 97.4% for negative DPT with macrolides. Conclusion: Confirmed macrolide allergy is rare in children, and DPTs are the gold standard to assess suspected macrolide allergy. The NPV of macrolide provocation tests seems to be high in children.
DergiAraştırma MakalesiErişime Açık
  • 1. Gomes ER, Brockow K, Kuyucu S, Saretta F, Mori F, Blanca-Lopez N, et al. Drug hypersensitivity in children: Report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy 2016;71:149-61.
  • 2. Chiriac AM, Demoly P. Drug provocation tests: Up-date and novel approaches. Allergy Asthma Clin Immunol 2013;9(1):12.
  • 3. Blondeau JM. The evolution and role of macrolides in infectious diseases. Expert Opin Pharmacother 2002;3:1131-51.
  • 4. Araújo L, Demoly P. Macrolides allergy. Curr Pharm Des 2008;14(27):2840-62.
  • 5. Guvenir H, Misirlioglu ED, Capanoglu M, Vezir E, Toyran M, Kocabas CN. Proven non-β-lactam antibiotic allergy in children. Int Arch Allergy Immunol 2016;169:45-50.
  • 6. Demoly P, Kropf R, Pichler W, Bircher A. Drug hypersensitivity: Questionnaire. Allergy 1999;54:999-1003.
  • 7. Norton AE, Konvinse K, Phillips EJ, Broyles AD. Antibiotic allergy in pediatrics. Pediatrics 2018;141:e20172497.
  • 8. Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs–an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013;68:702-12.
  • 9. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: General considerations. Allergy 2003;58:854-63.
  • 10. Vezir E, Dibek Misirlioglu E, Civelek E, Capanoglu M, Guvenir H, Ginis T, et al. Direct oral provocation tests in non‐immediate mild cutaneous reactions related to beta‐lactam antibiotics. Pediatr Allergy Immunol 2016;27:50-4.
  • 11. Cavkaytar O, Karaatmaca B, Yilmaz EA, Sekerel BE, Soyer O. Testing for clarithromycin hypersensitivity: A diagnostic challenge in childhood. J Allergy Clin Immunol Pract 2016;4:330-2. e1.
  • 12. Romano A, Atanaskovic-Markovic M, Barbaud A, Bircher AJ, Brockow K, Caubet JC, et al. Towards a more precise diagnosis of hypersensitivity to beta‐lactams—an EAACI position paper. Allergy 2020;75:1300-15.
  • 13. Mori F, Barni S, Pucci N, Rossi E, Azzari C, de Martino M, et al. Sensitivity and specificity of skin tests in the diagnosis of clarithromycin allergy. Ann Allergy Asthma Immunol 2010;104:417-9.
  • 14. Barni S, Butti D, Mori F, Pucci N, Rossi ME, Cianferoni A, et al. Azithromycin is more allergenic than clarithromycin in children with suspected hypersensitivity reaction to macrolides. J Investig Allergol Clin Immunol 2015;25(2):128.
  • 15. Ünal D, Demir S, Gelincik A, Olgaç M, Coşkun R, Çolakoğlu B, et al. Diagnostic value of oral challenge testing in the diagnosis of macrolide hypersensitivity. J Allergy Clin Immunol Pract 2018;6:521-7.
  • 16. Mori F, Pecorari L, Pantano S, Rossi ME, Pucci N, De Martino M, et al. Azithromycin anaphylaxis in children. Int J Immunopathol Pharmacol 2014;27:121-6.
  • 17. Chia F, Thong B. Macrolide allergy: Which tests are really useful? Allergol Immunopathol (Madr) 2011;39(4):191-2.
  • 18. Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, et al. Guideline for the diagnosis of drug hypersensitivity reactions. Allergo J Int 2015;24:94-105.
  • 19. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, et al. International Consensus on drug allergy. Allergy 2014;69:420-37.
  • 20. Ponvert C, Weilenmann C, Wassenberg J, Walecki P, Bourgeois ML, de Blic J, et al. Allergy to betalactam antibiotics in children: A prospective follow‐up study in retreated children after negative responses in skin and challenge tests. Allergy 2007;62:42-6.
  • 21. Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: Reliability of examination assessed by skin testing and oral challenge. J Pediatr 1998;132:137-43.
  • 22. Mendelson LM, Ressler C, Rosen JP, Selcow JE. Routine elective penicillin allergy skin testing in children and adolescents: Study of sensitization. J Allergy Clin Immunol 1984;73:76-81.
  • 23. Hershkovich J, Broides A, Kirjner L, Smith H, Gorodischer R. Beta lactam allergy and resensitization in children with suspected beta lactam allergy. Clin Exp Allergy 2009;39:726-30.
  • 24. Misirlioglu ED, Toyran M, Capanoglu M, Kaya A, Civelek E, Kocabas CN. Negative predictive value of drug provocation tests in children. Pediatr Allergy Immunol 2014;25:685-90.
  • 25. Williams DJ, Edwards KM, Self WH, Zhu Y, Arnold SR, McCullers JA, et al. Effectiveness of β-lactam monotherapy vs macrolide combination therapy for children hospitalized with pneumonia. JAMA Pediatr 2017;171:1184-91.
  • 26. Vyles D, Chiu A, Routes J, Castells M, Phillips EJ, et al. Antibiotic use after removal of penicillin allergy label. Pediatrics 2018;141:e20173466.
  • 27. Gerace K, Phillips E. Penicillin allergy label persists despite negative testing. J Allergy Clin Immunol Pract 2015;3(5):815-6.
  • 28. Trubiano JA, Adkinson NF, Phillips EJ. Penicillin allergy is not necessarily forever. JAMA 2017;318:82-3.
  • 29. Grinlington L, Choo S, Cranswick N, Gwee A. Non–β-lactam antibiotic hypersensitivity reactions. Pediatrics 2020;145(1):e20192256.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.